Skip to content
Assyro AI
Purple Book reference family · 351(a) biologic

taliglucerase alfa (Elelyso)

taliglucerase alfa is an FDA-licensed reference biologic from Pfizer Inc..

351(a) biologicBLA 022458 Pfizer Inc.
Biosimilars
0
Interchangeables
0
Listed patents
0
Reference approved
2012

Reference product

Originator biologic
Ask AI
351(a)BLA 022458

Elelyso taliglucerase alfa

Pfizer Inc.

View full reference-product record
Approved
Marketing
Rx
Center
CDER
Patents
None listed

Exclusivity & patent cliffs

Protection horizon
Ask AI
  1. Reference approval

    Approval date of the reference taliglucerase alfa product.

    14 yr 9 mo ago

taliglucerase alfa: frequently asked questions

Reference exclusivity, biosimilars, interchangeability, and patents for this molecule, from the FDA Purple Book.

Built from official FDA Purple Book records (monthly downloads, the Advanced Search interface, and the published Patent List), with reference-product, license-type, and exclusivity context for taliglucerase alfa.

Related FDA reference tools

Assyro Intelligence

Ask anything about taliglucerase alfa

Cited answers from FDA, EMA, Health Canada, PubMed and ClinicalTrials.gov, in seconds. Free, no sign-up.

  • PubMed
  • ClinicalTrials.gov
  • FDA
  • Health Canada
  • EMA
  • ICH

Evaluating for a team? Book a demo